KPIs & Operating Metrics(New)
Assets By SegmentBreakdown Of AssetsCapital Expenditure By SegmentContractual ObligationsCost Of Goods SoldDeferred RevenueEmployee StatisticsGross Margin %Gross Margin Annual %Gross ProfitGross Profit AnnualIncome Before Income Tax By RegionNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Operating Margin By Segment %Operating Margin By Segment Annual %Operating Profit (Loss) By SegmentOperating Profit (Loss) By Segment AnnualOpex As A % Of Total Revenue %OPEX SegregationProperty And Equipment By GeographyProperty And Equipment, Net BreakdownRevenue By GeographyRevenue By Geography %Revenue By Geography AnnualRevenue By Geography Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio-Rad Laboratories (BIO) Gross Profit (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Gross Profit for 17 consecutive years, with $345.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Gross Profit rose 0.96% to $345.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.3 billion, a 2.82% decrease, with the full-year FY2025 number at $1.3 billion, down 2.83% from a year prior.
  • Gross Profit was $345.2 million for Q4 2025 at Bio-Rad Laboratories, up from $343.4 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $436.5 million in Q3 2021 to a low of $306.0 million in Q1 2025.
  • A 5-year average of $367.5 million and a median of $362.4 million in 2023 define the central range for Gross Profit.
  • Peak YoY movement for Gross Profit: soared 36.89% in 2021, then fell 14.64% in 2022.
  • Bio-Rad Laboratories' Gross Profit stood at $399.9 million in 2021, then fell by 0.71% to $397.1 million in 2022, then dropped by 7.74% to $366.3 million in 2023, then fell by 6.66% to $341.9 million in 2024, then rose by 0.96% to $345.2 million in 2025.
  • Per Business Quant, the three most recent readings for BIO's Gross Profit are $345.2 million (Q4 2025), $343.4 million (Q3 2025), and $345.3 million (Q2 2025).